TriSalus Life Sciences, Inc. TLSI Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableTradeCurrent.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s accounts payable?
- TriSalus Life Sciences, Inc. (TLSI) reported accounts payable of $4.23M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s accounts payable changed year-over-year?
- TriSalus Life Sciences, Inc.'s accounts payable increased by 50.8% year-over-year, from $2.81M to $4.23M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), TriSalus Life Sciences, Inc.'s accounts payable has grown at a 96.2% compound annual growth rate (CAGR), from $103.22K to $3M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.